NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05489211 2026-03-19Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)AstraZenecaPhase 2 Recruiting454 enrolled
NCT00005049 2011-04-06Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerNYU Langone HealthPhase 2 Completed45 enrolled